Research Article - (2012) Volume 3, Issue 3
Safety Modality for X-linked Severe Combined Immunodeficiency Gene Therapy
- Nicole Scheumann1,3#, Elisa Kieback1# and Wolfgang Uckert1,2*
- 1Max-Delbrueck-Center for Molecular Medicine, Robert-Roessle-Strasse 10, D-13092 Berlin, Germany
- 2Humboldt-University of Berlin, Institute of Biology, Robert-Roessle-Strasse 10, D-13092 Berlin, Germany
- 3Sir William Dunn School of Pathology, University of Oxford, South Parks Road, Oxford OX1 3RE, United Kingdom
- #Contributed equally to this work
*Corresponding Author:
Wolfgang Uckert, Max-Delbrueck-Center for Molecular Medicine, Robert-Roessle-Strasse 10, D-13092 Berlin, Germany, Tel: +49-30-94063196, Fax: +49-30-94063306
Email:
